title: Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation.
abstract: A B-lymphoblastoid cell line ESKOL, composed of differentiated cells resembling hairy-cell leukemia (HCL) has been established from the peripheral blood (PB) of a HCL patient. Morphologically, ESKOL cells share several features with HCL B cells. Flow cytometric analysis revealed that ESKOL cells express HC2, CD21, PCA-1, CD24, FMC7, and CD25. Analysis by Northern-blot hybridization indicated that cultured cells expressed the oncogenes c-myc, H-ras and c-fos. RNA from 3T3 cells transfected with ESKOL DNA hybridized with H-ras and c-fos DNA probes. The ESKOL cells cultured in the presence of increasing concentrations, of alpha interferon demonstrated a decrease in the rate of cellular growth and an increase in the expression of CD21, CD25, FMC7 and PCA-1. Scanning electron microscopy revealed that cells incubated in the presence of alpha interferon underwent membranous changes with a loss of villosity. These observations suggest that IFN tends to drive HC out of their developmental arrest towards maturation.
authors.affiliation: Department of Biology, Earlham College, Richmond, IN 47374.
authors.forename: W
authors.initials: W
authors.lastname: Harvey
authors.forename: E F
authors.initials: EF
authors.lastname: Srour
authors.forename: R
authors.initials: R
authors.lastname: Turner
authors.forename: R
authors.initials: R
authors.lastname: Carey
authors.forename: R
authors.initials: R
authors.lastname: Maze
authors.forename: B
authors.initials: B
authors.lastname: Starrett
authors.forename: R
authors.initials: R
authors.lastname: Kanagala
authors.forename: D
authors.initials: D
authors.lastname: Pereira
authors.forename: P
authors.initials: P
authors.lastname: Merchant
authors.forename: M
authors.initials: M
authors.lastname: Taylor
mesh_terms: D000368:Aged; D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D000954:Antigens, Surface / Q000032:analysis; D000956:Antigens, Viral / Q000032:analysis; D001402:B-Lymphocytes / Q000473:pathology* / Q000502:physiology; D002454:Cell Differentiation / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D004273:DNA, Neoplasm / Q000235:genetics; D019309:Epstein-Barr Virus Nuclear Antigens; D015973:Gene Expression Regulation, Leukemic / Q000502:physiology*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology; D007943:Leukemia, Hairy Cell / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D008297:Male; D011994:Recombinant Proteins; D014407:Tumor Cells, Cultured / Q000276:immunology
chemical_list: D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D000956:Antigens, Viral; D004273:DNA, Neoplasm; D019309:Epstein-Barr Virus Nuclear Antigens; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins